Furthermore, we have also verified the regulatory signaling of LINC01273/miR-600/METTL3 in vivo, suggesting that dysregulation of LINC01273/miR-600/METTL3 axis may be responsible for sorafenib resistance in HCC cells. This evidence concerns the gene LINC01273 and hepatocellular carcinoma.